Suchergebnisse - "Boudville, Neil"

PubPharm (243)

1

Association between diabetic status and risk of all-cause and cause-specific mortality on dialysis following first kidney allograft loss

enthalten in: Clinical kidney journal | 2024

von Samarasinghe, A. | Wong, G. | Teixeira-Pinto, A. | +13

2

Risk of Relapse of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis in a Randomized Controlled Trial of Plasma Exchange and Glucocorticoids

enthalten in: Arthritis & rheumatology (Hoboken, N.J.) | 2024

von Junek, M. | Merkel, P. | Vilayur, E. | +105

3

Gastric Acid Suppression Therapy and Its Association with Peritoneal Dialysis-Associated Peritonitis in the Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS)

enthalten in: Kidney360 | 2024

von Goldman, S. | Zhao, J. | Bieber, B. | +12

4

Postoperative Outcomes After Gastrointestinal Surgery in Patients Receiving Chronic Kidney Replacement Therapy : A Population-based Cohort Study

enthalten in: Annals of surgery | 2024

von Palamuthusingam, D. | Hawley, C. | Pascoe, E. | +6

5

Associations of neutral pH, low-GDP peritoneal dialysis solutions with patient survival, transfer to haemodialysis and peritonitis

enthalten in: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association | 2024

von Chen, J. | Johnson, D. | Cho, Y. | +8

ErratumIn: Nephrol Dial Transplant. 2024 Apr 10;:. - PMID 38597605

6

Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis

enthalten in: The New England journal of medicine | 2023

von Rheault, M. | Alpers, C. | Barratt, J. | +125

CommentIn: N Engl J Med. 2024 Mar 21;390(12):1153-1154. - PMID 38507767

7

Can Telehealth Improve Access to Dietary Management in Patients Receiving Dialysis? Insights from Consumers

enthalten in: Nutrients | 2023

von Beer, J. | Lambert, K. | Lim, W. | +2

8

Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT) : 2-year results from a randomised, active-controlled, phase 3 trial

enthalten in: Lancet (London, England) | 2023

von Rovin, B. | Barratt, J. | Heerspink, H. | +130

CommentIn: Lancet. 2023 Dec 2;402(10417):2046-2047. - PMID 37931627

9

Multi-center, pragmatic, cluster-randomized, controlled trial of standardized Peritoneal Dialysis (PD) training versus usual care on PD-related infections (The TEACH-PD Trial): Trial Protocol

enthalten in: ResearchSquare.com | 2023

von Chow, J. | Boudville, N. | Cho, Y. | +35

10

Multi-center, pragmatic, cluster-randomized, controlled trial of standardized peritoneal dialysis (PD) training versus usual care on PD-related infections (the TEACH-PD trial) : trial protocol

enthalten in: Trials | 2023

von Chow, J. | Boudville, N. | Cho, Y. | +35

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[25]